Did pharma sector dodge Trump’s tariffs? The EU's not so sure

euronews (in English)

Did pharma sector dodge Trump’s tariffs? The EU's not so sure  The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely.  READ MORE : http://www.euronews.com/2025/04/03/did-pharma-sector-dodge-trumps-tariffs-the-eus-not-so-sure  Subscribe to our channel. Euronews is available on Dailymotion in 12 languages

Transcript

00:00Surprisingly, the US president didn't impose tariffs on the pharmaceutical industry.

00:11Although relieved, the EU pharma companies remain on alert because that can change, as

00:16they say.

00:18The words used to announce customs tariffs were not very specific.

00:27In fact, the word used was pharmaceuticals.

00:31Is it only about finished products or is it also, for example, elements that are

00:37necessary to make up a drug?

00:40That's not entirely clear, so we are relieved, but we remain very vigilant and call

00:46for action at the European level to strengthen our competitiveness in the sector.

00:53Why could Trump exclude pharmaceutical products from the tariffs?

00:58Pharmaceutical products, including medicines, are internationally required to be price

01:03protected for the benefit of patients.

01:07So, a huge price increase isn't easily possible.

01:12Another reason may be that the US relies heavily on European pharmaceutical imports.

01:18At the same time, many large pharmaceutical companies are American.

01:42If tariffs are imposed on drugs, pharmaceuticals are expected to become more expensive.

01:52But the most important part is availability.

01:56If the product is so expensive that demand drops, production may also decrease.

Category

Transcript

Recommended